Subscribe to RSS
DOI: 10.1055/s-2007-971022
Komplikationen und Spätfolgen nach Rückenmarktrauma
Complications and Late Sequelae of Spinal Cord TraumaPublication History
Publication Date:
05 October 2007 (online)
Lernziele
Lernziel 1: Die autonome Dysreflexie (AD) ist ein Syndrom mit möglichen lebensbedrohlichen Komplikationen, die bei Rückenmarkläsionen oberhalb von Th6 auftritt. Lernziel 2: Die autonome Dysreflexie kann, wenn nicht früh genug erkannt und behandelt, zu schwerwiegenden Komplikationen wie Blutdruckkrisen und Vasospasmen führen. Lernziel 3: Häufige Ursachen einer autonomen Dysreflexie sind Komplikationen im abdominalen Bereich wie Blaseninfektionen, verstopfte Blasenkatheter oder Hautreize durch Entzündungen oder Verbrennungen sowie Reize durch diagnostische Eingriffe. Lernziel 4: Bei rückenmarksverletzten Patienten sollte bei Veränderungen des neurologischen Status mittels Magnetresonanztomographie des Myelons eine posttraumatische Syringomyelie ausgeschlossen werden. Lernziel 5: Bei lokaler Temperaturerhöhung mit Rötung, Ödem und Bewegungseinschränkung eines Gelenkes sollte bei querschnittgelähmten Patienten an eine neurogen bedingte heterotope Ossifikation gedacht werden.
Literatur
- 1 Paeslack V. 25 years Heidelberg Rehabilitation Center for Spinal Cord Injuries - retrospect and prospects. Rehabilitation (Stuttg). 1992; 31 138-142
- 2 De Vivo M J, Stover S L, Black K J. Prognostic factors for 12-year survival after spinal cord injury. Arch Phys Med Rehabil. 1992; 73 156-162
- 3 Wahle H. 10-year follow-up of occupational integration of 50 patients with complete paraplegia. Rehabilitation (Stuttg). 1990; 29 112-120
- 4 Guttmann F L, Whitteridge D. Effects of bladder distension on autonomic mechanisms after spinal cord injury. Brain. 1947; 20 361-404
- 5 Krassioukov A V, Furlan J C, Fehlings M G. Autonomic dysreflexia in acute spinal cord injury: an under-recognized clinical entity. J Neurotrauma. 2003; 20 707-716
- 6 Finestone H M, Teasell R W. Autonomic dysreflexia after brainstem tumor resection. A case report. Am J Phys Med Rehabil. 1993; 72 395-397
- 7 Sandel M E, Abrams P L, Horn L J. Hypertension after brain injury: case report. Arch Phys Med Rehabil. 1986; 67 469-472
- 8 Lindan R. et al . Incidence and clinical features of autonomic dysreflexia in patients with spinal cord injury. Paraplegia. 1980; 18 285-292
- 9 Thyberg M. et al . Effect of nifedipine on cystometry-induced elevation of blood pressure in patients with a reflex urinary bladder after a high level spinal cord injury. Paraplegia. 1994; 32 308-313
- 10 Helkowski W M, Ditunno Jr J F, Boninger M. Autonomic dysreflexia: incidence in persons with neurologically complete and incomplete tetraplegia. J Spinal Cord Med. 2003; 26 244-247
- 11 Aito S. Complications during the acute phase of traumatic spinal cord lesions. Spinal Cord. 2003; 41 629-635
- 12 Curt A. et al . Assessment of autonomic dysreflexia in patients with spinal cord injury. J Neurol Neurosurg Psychiatry. 1997; 62 473-477
- 13 Schurch B, Knapp P A, Rossier A B. Autonomic hyperreflexia revisited. Urol Int. 1997; 58 148-152
- 14 Karlsson A K. Autonomic dysreflexia. Spinal Cord. 1999; 37 383-391
- 15 Blackmer J. Rehabilitation medicine: 1. Autonomic dysreflexia. Cmaj. 2003; 169 931-935
- 16 Kewalramani L S. Autonomic dysreflexia in traumatic myelopathy. Am J Phys Med. 1980; 59 1-21
- 17 Kursh E D, Freehafer A, Persky L. Complications of autonomic dysreflexia. J Urol. 1977; 118 70-72
- 18 Guttmann L, Frankel H L, Paeslack V. Cardiac irregularities during labour in paraplegic women. Paraplegia. 1965; 3 144-151
- 19 Forrest G P. Atrial fibrillation associated with autonomic dysreflexia in patients with tetraplegia. Arch Phys Med Rehabil. 1991; 72 592-594
- 20 Pine Z M, Miller S D, Alonso J A. Atrial fibrillation associated with autonomic dysreflexia. Am J Phys Med Rehabil. 1991; 70 271-273
- 21 Karlsson A K. et al . Regional sympathetic function in high spinal cord injury during mental stress and autonomic dysreflexia. Brain. 1998; 121 1711-1719
- 22 Naftchi N E. Mechanism of autonomic dysreflexia. Contributions of catecholamine and peptide neurotransmitters. Ann NY Acad Sci. 1990; 579 133-148
- 23 Mathias C J. et al . Dopamine beta-hydroxylase release during hypertension from sympathetic nervous overactivity in man. Cardiovasc Res. 1976; 10 176-181
- 24 Chiou-Tan F Y, Robertson C S, Chiou G C. Catecholamine assays in a rat model for autonomic dysreflexia. Arch Phys Med Rehabil. 1998; 79 402-404
- 25 Zhou G C. et al . The determination of vasoactive substances during autonomic dysreflexia. Spinal Cord. 1997; 35 390-393
- 26 Lee B Y. et al . Autonomic dysreflexia revisited. J Spinal Cord Med. 1995; 18 75-87
- 27 Manger W M, Davis S W, Chu D S. Autonomic hyperreflexia and its differentiation from pheochromocytoma. Arch Phys Med Rehabil. 1979; 60 159-161
- 28 Shapiro B, Fig L M. Management of pheochromocytoma. Endocrinol Metab Clin North Am. 1989; 18 443-481
- 29 Bravo E L. et al . Clonidine-suppression test: a useful aid in the diagnosis of pheochromocytoma. N Engl J Med. 1981; 305 623-626
- 30 Schurch B, Yasuda K, Rossier A B. Detrusor bladder neck dyssynergia revisited. J Urol. 1994; 152 2066-2070
- 31 Giannantoni A. et al . Autonomic dysreflexia during urodynamics. Spinal Cord. 1998; 36 756-760
- 32 Dunn K L. Autonomic dysreflexia: a nursing challenge in the care of the patient with a spinal cord injury. J Cardiovasc Nurs. 1991; 5 57-64
- 33 McGuire T J, Kumar V N. Autonomic dysreflexia in the spinal cord-injured. What the physician should know about this medical emergency. Postgrad Med. 1986; 80 81-84, 89
- 34 Gerber J G. et al . The antihypertensive efficacy of hydrochlorothiazide is not prostacyclin dependent. Clin Pharmacol Ther. 1990; 48 424-430
- 35 Braddom R L, Rocco J F. Autonomic dysreflexia. A survey of current treatment. Am J Phys Med Rehabil. 1991; 70 234-241
- 36 Anton H A, Townson A A, Strong G F. Consortion for Spinal Cord Medicine .Acute management of autonomic dysreflexia individuals with spinal cord injury presenting to health care facilities (clinical practice guideline). Washington; T.C.P.V.o.A.n. ed, Editor 2001
- 37 Anton H A, Townson A. Drug therapy for autonomic dysreflexia. Cmaj. 2004; 170 1210; author reply 1210
- 38 Esmail Z. et al . Evaluation of captopril for the management of hypertension in autonomic dysreflexia: a pilot study. Arch Phys Med Rehabil. 2002; 83 604-608
- 39 Colachis 3rd S C. Autonomic hyperreflexia with spinal cord injury. J Am Paraplegia Soc. 1992; 15 171-186
- 40 Barton C H. et al . The effect of modified transurethral sphincterotomy on autonomic dysreflexia. J Urol. 1986; 135 83-85
- 41 Perkash I. Transurethral sphincterotomy provides significant relief in autonomic dysreflexia in spinal cord injured male patients: long-term follow-up results. J Urol. 2007; 177 1026-1029
- 42 Schurch B. et al . Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients. J Urol. 1996; 155 1023-1029
- 43 Schurch B. Botulinum toxin for the management of bladder dysfunction. Drugs. 2006; 66 1301-1318
- 44 Schurch B. et al . Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol. 2005; 174 196-200
- 45 Schurch B. et al . Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000; 164 692-697
- 46 Brindley G S. The first 500 patients with sacral anterior root stimulator implants: general description. Paraplegia. 1994; 32 795-805
- 47 Rossier A B. et al . Posttraumatic cervical syringomyelia. Incidence, clinical presentation, electrophysioogical studies, syrinx protein and results of conservative and operative treatment. Brain. 1985; 108 439-461
- 48 el Masry W S, Biyani A. Incidence, management, and outcome of post-traumatic syringomyelia. In memory of Mr Bernard Williams. J Neurol Neurosurg Psychiatry. 1996; 60 141-146
- 49 Schurch B, Wichmann W, Rossier A B. Post-traumatic syringomyelia (cystic myelopathy): a prospective study of 449 patients with spinal cord injury. J Neurol Neurosurg Psychiatry. 1996; 60 61-67
- 50 Sgouros S, Williams B. Management and outcome of posttraumatic syringomyelia. J Neurosurg. 1996; 85 197-205
- 51 Strümpell A. Beiträge zur Pathologie des Rückenmarks. Arch Psychiatr Nervenkr. 1880; 10 676-717
- 52 Schurch B, Dietz V. Postraumatische Syringomyelie, in Klinik der Rückenmarkschädigung. Stuttgart; Kohlhammer 2001: 248-253
- 53 Wang D. et al . A clinical magnetic resonance imaging study of the traumatised spinal cord more than 20 years following injury. Paraplegia. 1996; 34 65-81
- 54 Perrouin-Verbe B. et al . Post-traumatic syringomyelia and post-traumatic spinal canal stenosis: a direct relationship: review of 75 patients with a spinal cord injury. Spinal Cord. 1998; 36 137-143
- 55 Kakulas B A. The clinical neuropathology of spinal cord injury. A guide to the future. Paraplegia. 1987; 25 212-216
- 56 Madsen 3rd P W, Yezierski R P, Holets V R. Syringomyelia: clinical observations and experimental studies. J Neurotrauma. 1994; 11 241-254
- 57 Williams B. Pathogenesis of post-traumatic syringomyelia. Br J Neurosurg. 1992; 6 517-520
- 58 Oldfield E H. et al . Pathophysiology of syringomyelia associated with Chiari I malformation of the cerebellar tonsils. Implications for diagnosis and treatment. J Neurosurg. 1994; 80 3-15
- 59 Tator C H, Briceno C. Treatment of syringomyelia with a syringosubarachnoid shunt. Can J Neurol Sci. 1988; 15 48-57
- 60 Milhorat T H. et al . Pathological basis of spinal cord cavitation in syringomyelia: analysis of 105 autopsy cases. J Neurosurg. 1995; 82 802-812
- 61 Qiu Y. et al . Radiologic presentations in relation to curve severity in scoliosis associated with syringomyelia. Stud Health Technol Inform. 2006; 123 543-548
- 62 Brodbelt A R. et al . The role of excitotoxic injury in post-traumatic syringomyelia. J Neurotrauma. 2003; 20 883-893
- 63 Shannon N. et al . Clinical features, investigation and treatment of post-traumatic syringomyelia. J Neurol Neurosurg Psychiatry. 1981; 44 35-42
- 64 Reddy K K, Del Bigio M R, Sutherland G R. Ultrastructure of the human posttraumatic syrinx. J Neurosurg. 1989; 71 239-243
- 65 Qiu Y. et al . Clinical manifestations and significance of post-traumatic thoracolumbar syringomyelia. Chin J Traumatol. 2004; 7 52-55
- 66 Backe H A. et al . Post-traumatic spinal cord cysts evaluated by magnetic resonance imaging. Paraplegia. 1991; 29 607-612
- 67 Modic M T. et al . Magnetic resonance imaging of the cervical spine: technical and clinical observations. AJR Am J Roentgenol. 1983; 141 1129-1136
- 68 Freund M. et al . Posttraumatic syringomyelia: volumetric phantom and patient studies using MR imaging. Eur Radiol. 2002; 12 2965-2972
- 69 Lee T T. et al . Outcome after surgical treatment of progressive posttraumatic cystic myelopathy. J Neurosurg. 2000; 92, 2 Suppl 149-154
- 70 Quencer R M. et al . Intraoperative sonography in spinal dysraphism and syringohydromyelia. AJR Am J Roentgenol. 1987; 148 1005-1013
- 71 Tobimatsu Y. et al . A quantitative analysis of cerebrospinal fluid flow in post-traumatic syringomyelia. Paraplegia. 1995; 33 203-207
- 72 Benedetto M D, Rossier A B. Electrodiagnosis in post-traumatic syringomyelia. Paraplegia. 1977; 14 2862-2895
- 73 Peerless S J, Durward Q J. Management of syringomyelia: a pathophysiological approach. Clin Neurosurg. 1983; 30 531-576
- 74 Biyani A, el Masry W S. Post-traumatic syringomyelia: a review of the literature. Paraplegia. 1994; 32 723-731
- 75 Abel R. et al . Residual deformity of the spinal canal in patients with traumatic paraplegia and secondary changes of the spinal cord. Spinal Cord. 1999; 37 14-19
- 76 Falci S P. et al . Surgical treatment of posttraumatic cystic and tethered spinal cords. J Spinal Cord Med. 1999; 22 173-181
- 77 Heuck F, Euchenhofer M. X-ray findings of paraosteoarthropathy during intensive care treatment after intoxication (author's transl). Radiologe. 1974; 14 470-477
- 78 Benassy J. et al . Ostéomes des paraplégiques. Presse médicale. 1960; 68 811-814
- 79 Furman R, Nicholas J J, Jivoff L. Elevation of the serum alkaline phosphatase coincident with ectopic-bone formation in paraplegic patients. J Bone Joint Surg Am. 1970; 52 1131-1137
- 80 Garland D E. Surgical approaches for resection of heterotopic ossification in traumatic brain-injured adults. Clin Orthop Relat Res. 1991; 263 59-70
- 81 Stover S L, Niemann K M, Tulloss J R. Experience with surgical resection of heterotopic bone in spinal cord injury patients. Clin Orthop Relat Res. 1991; 263 71-77
- 82 Schurch B. et al . Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients. Arch Phys Med Rehabil. 1997; 78 687-691
- 83 Bergmann P. et al . Longitudinal study of calcium and bone metabolism in paraplegic patients. Paraplegia. 1977; 15 147-159
- 84 Rossier A B. et al . Current facts of para-osteo-arthropathy (POA). Paraplegia. 1973; 11 38-78
- 85 Chantraine A. Clinical investigation of bone metabolism in spinal cord lesions. Paraplegia. 1971; 8 253-259
- 86 High W B. Effects of orally administered prostaglandin E-2 on cortical bone turnover in adult dogs: a histomorphometric study. Bone. 1987; 8 363-373
- 87 Jee W S. et al . The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2. Bone. 1987; 8 171-178
- 88 Kozawa O. et al . Cross-talk regulation between cyclic AMP production and phosphoinositide hydrolysis induced by prostaglandin E2 in osteoblast-like cells. Exp Cell Res. 1992; 198 130-134
- 89 Rahman S. et al . Bradykinin stimulates the production of prostaglandin E2 and interleukin-6 in human osteoblast-like cells. Biochim Biophys Acta. 1992; 1135 97-102
- 90 Harada S. et al . Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. J Clin Invest. 1994; 93 2490-2496
- 91 Tokuda H. et al . Intracellular signaling mechanism of bradykinin in osteoblast-like cells: comparison with prostaglandin E2. Endocr J. 1994; 41 189-195
- 92 Singh R S. et al . The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury. Arch Phys Med Rehabil. 2003; 84 1584-1588
- 93 Welch K M, Goldberg D M. Serum creatine phosphokinase in motor neuron disease. Neurology. 1972; 22 697-701
- 94 Sherman A L. et al . The value of serum creatine kinase in early diagnosis of heterotopic ossification. J Spinal Cord Med. 2003; 26 227-230
- 95 Freed J H. et al . The use of the three-phase bone scan in the early diagnosis of heterotopic ossification (HO) and in the evaluation of Didronel therapy. Paraplegia. 1982; 20 208-216
- 96 Tanaka T. et al . Quantitative assessment of para-osteo-arthropathy and its maturation on serial radionuclide bone images. Radiology. 1977; 123 217-221
- 97 Ahrengart L, Lindgren U, Reinholt F P. Comparative study of the effects of radiation, indomethacin, prednisolone, and ethane-1-hydroxy-1,1-diphosphonate (EHDP) in the prevention of ectopic bone formation. Clin Orthop Relat Res. 1988; 229 265-273
- 98 Sautter-Bihl M L, Liebermeister E, Nanassy A. Radiotherapy as a local treatment option for heterotopic ossifications in patients with spinal cord injury. Spinal Cord. 2000; 38 33-36
- 99 Meiners T. et al . Resection of heterotopic ossification of the hip in spinal cord injured patients. Spinal Cord. 1997; 35 443-445
- 100 Tow A P, Kong K H. Prolonged fever and heterotopic ossification in a C4 tetraplegic patient. Case report. Paraplegia. 1995; 33 170-174
- 101 Kirshblum S C. et al . Spinal cord injury medicine. 3. Rehabilitation phase after acute spinal cord injury. Arch Phys Med Rehabil. 2007; 88, 3 Suppl 1 S62-70
- 102 Garland D E, Orwin J F. Resection of heterotopic ossification in patients with spinal cord injuries. Clin Orthop Relat Res. 1989; 242 169-176
Prof. Dr. B. Schurch
Paraplegikerzentrum, Universitätsklinik Balgrist
Forchstr. 340
8008 Zürich, Schweiz
Email: bschurch@paralab.balgrist.ch